---
document_datetime: 2023-09-21 20:02:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/duavive-epar-all-authorised-presentations_en.pdf
document_name: duavive-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6450398
conversion_datetime: 2025-12-24 21:18:29.648322
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical form     | Route of administration   | Immediate Packaging       | Pack size   |
|------------------|-------------------|-----------------|-------------------------|---------------------------|---------------------------|-------------|
| EU/1/14/960/001  | DUAVIVE           | 0.45 mg / 20 mg | Modified-release tablet | Oral use                  | blister (PVC/ Aclar/ PVC) | 28 tablets  |